Sipra Labs Private Limited is set to become leading player in providing technical services of international quality to the drugs and pharmaceutical industry. Sipra is equipped with state-of- the-art technology associated with the qualified scientists and pharmacists to conduct various studies under one roof with strict compliance of GLP and ISO guide lines.

Dr Vemulapalli Satyanarayana, the managing director of Sipra Labs said that Sipra was the first in South India to get the approval of DCGI for its bio-equivalence centre for conducting specialized studies for new drugs. It has a bed capacity of more than 50 for conducting clinical studies along with an experienced team of doctors and phelobotomists. In addition said all the tests are conducted in-house in accordance with NABL (National Accreditation Board for Testing and Calibration Laboratories) guidelines.

The bio-analytical labs are equipped with LC-MS/Ms and six binary/quarternary HPLCs systems with auto sampler with programmable injection facilities. Sipra labs systems were subject to audit regularly by many national and internation agencies and we are proud to say that we have the highest number Standard Operating Procedures and systems in place among these type of laboratories in India.

Sipra Labs has specialized centres for bio-equivalence, chemical, microbiological and method development studies.